Labcorp Q3 FY24: where the revenue came from and where it went
The whole income statement of Labcorp for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2024
- Reported
- Oct 29, 2024
Revenue$3.28B
+7% year over year
Gross profit$0.90B
28% margin
Operating profit$0.25B
8% margin
Net profit$0.17B
5% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.28 | 100% | +7% |
| Diagnostics | 2.55 | 78% | +9% |
| Drug development | 0.74 | 22% | +3% |
| Cost of revenue | −2.38 | 72% | |
| Gross profit | 0.90 | 28% margin | +0pp |
| SG&A | −0.57 | 17% | +0pp |
| Other | −0.08 | 3% | +0pp |
| Operating profit | 0.25 | 8% margin | −1pp |
| Interest & other costs | −0.04 | ||
| Tax | −0.04 | ||
| Net profit | 0.17 | 5% margin | −1pp |
122 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest